Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07690579 · ClinicalTrials.gov registry record
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 350
- Enrollment target
NCT07690579 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 350 participants.
The verdict
NCT07690579 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
Study Summary
Prostate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States. PC among Black men accounts for a higher proportion alike of cancer diagnoses and deaths. In the prostate specific antigen (PSA)-based screening era, mortality rates improved at a similar velocity among Black and White men, but the 2- to 3-fold excess mortality burden borne by Black men has persisted over the past 40 years, the second highest among all major cancers. In recent years mortality is rising among Black men, and at a rapid velocity. The explanations for this disparity-the extent to which it is attributable to genetics, environmental factors including Structural and Social Determinants of Health (SSDH), or access to care-are multifactorial and have been elucidated to a limited extent. A large meta-analysis recently found that across dozens of studies and cohorts, greater adjustment for clinical and SSDH factors generally resulted in race itself dropping as a significant predictor. These and other findings suggest that the determinants of disparity be identified at time of, and prior to, cancer diagnosis, and that both genetic and environmental factors contribute to earlier development and progression.
Interventions
- OTHER Questionnaires
- OTHER Medical Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2028-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07690579
The ClinicalTrials.gov registry entry for NCT07690579 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT07690579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07690579 about?
NCT07690579 is a clinical study titled "Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities". Prostate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States. PC among Black men accounts for a higher proportion alike of cancer diagnoses and deaths. In the prostate specific antigen (PSA)-based screening era...
What is the current status of trial NCT07690579?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2026-03-31. Estimated completion is 2028-03-31.
What interventions are being tested in trial NCT07690579?
The interventions under investigation include: Questionnaires (OTHER), Medical Record Review (OTHER).
Who is sponsoring clinical trial NCT07690579?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.